Skip to content
Riskpilot
← Back to search
Sign in
Get full access
EndoGyn Sverige AB
AB
Active
Org 5594305921
Kvarnholmsvägen 92, 131 31
Nacka
Medical specialists activities
·
NACE 8622
Est. 2023 · 3 years old
20-49 employees
Monitor
Share
Sweden
/
Companies
/
Medical specialists activities
/
EndoGyn Sverige AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
2M
5M
7M
9M
0M
2023
8M
2024
EBITDA
SEK millions
0M
-1M
-3M
-4M
-5M
-2M
2023
-4M
-100%
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
0
8 050
Staff expenses
−1 567
−7 783
EBITDA
−1 981
−3 917
Depreciation & amort.
—
−192
EBIT
−1 981
−4 109
Net financials
27
−168
Profit before tax
−1 955
−4 278
Tax
—
—
Net profit
−1 955
−4 278
Balance sheet
SEK thousands
Item
2023
2024
Total assets
4 288
6 310
Equity
3 070
1 495
Long-term debt
—
2 139
Short-term debt
1 217
2 676
Total debt
1 217
4 815
Financial ratios
5-year trend
EBITDA margin
-48.7%
This company
15.8%
Market median
-408% vs market
2023
2024
Equity ratio
23.7%
This company
38.2%
Market median
-38% vs market
2023
2024
Return on equity
-286.2%
This company
18.4%
Market median
-1655% vs market
2023
2024
Net profit margin
-53.1%
This company
8.1%
Market median
-756% vs market
2023
2024
Asset turnover
1.28×
This company
1.12×
Market median
+14% vs market
2023
2024
Debt / equity
3.22×
This company
0.62×
Market median
-419% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-04-17 – 2023-12-31
View
PDF
More on EndoGyn Sverige AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
